Nicotinamide Mononucleotide, a Key NAD+ Intermediate, Treats the Pathophysiology of Diet- and Age-Induced Diabetes in MiceJun Yoshino, Shin‐ichiro Imai, Kathryn F. Mills et al.|Cell Metabolism|2011Cited by 1.3k
Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in MiceKathryn F. Mills, Shin‐ichiro Imai, Shohei Yoshida et al.|Cell Metabolism|2016Cited by 900
Nampt/PBEF/Visfatin Regulates Insulin Secretion in β Cells as a Systemic NAD Biosynthetic EnzymeJavier R. Revollo, Shin‐ichiro Imai, Antje Körner et al.|Cell Metabolism|2007Cited by 899
Extracellular Vesicle-Contained eNAMPT Delays Aging and Extends Lifespan in MiceMitsukuni Yoshida, Shin‐ichiro Imai, Rajendra S. Apte et al.|Cell Metabolism|2019Cited by 416
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic womenMihoko Yoshino, Samuel Klein, Jun Yoshino et al.|Science|2021Cited by 415